Related references
Note: Only part of the references are listed.Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes
Stephen Harrow et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Preoperative Paravertebral Block and Chronic Pain after Breast Cancer Surgery: A Double-blind Randomized Trial
Aline Albi-Feldzer et al.
ANESTHESIOLOGY (2021)
Informative censoring due to missing data in quality of life was inadequately assessed in most oncology randomized controlled trials
Timothee Olivier et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review
Johannes M. Giesinger et al.
VALUE IN HEALTH (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019
Fabio Efficace et al.
VALUE IN HEALTH (2021)
Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review
Sergiusz Lukasiewicz et al.
CANCERS (2021)
Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation
Julius K. Weng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy
Peter A. Kaufman et al.
ONCOLOGIST (2020)
Dexamethasone Dose and Early Postoperative Recovery after Mastectomy A Double-blind, Randomized Trial
Kristin Julia Steinthorsdottir et al.
ANESTHESIOLOGY (2020)
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium
Corneel Coens et al.
LANCET ONCOLOGY (2020)
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer
Yvonne Brandberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial
Madeleine T. King et al.
LANCET ONCOLOGY (2020)
Health-RelatedQuality of Life inMONARCH3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy inHR+,HER2-Advanced Breast Cancer
Matthew P. Goetz et al.
ONCOLOGIST (2020)
Demystifying the estimand framework: a case study using patient-reported outcomes in oncology
Mallorie H Fiero et al.
LANCET ONCOLOGY (2020)
A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting
M. Clemons et al.
BREAST (2020)
Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial
S. Delaloge et al.
ANNALS OF ONCOLOGY (2019)
Perioperative Pregabalin and Intraoperative Lidocaine Infusion to Reduce Persistent Neuropathic Pain After Breast Cancer Surgery: A Multicenter, Factorial, Randomized, Controlled Pilot Trial
James S. Khan et al.
JOURNAL OF PAIN (2019)
PubMed coverage varied across specialties and over time: a large-scale study of included studies in Cochrane reviews
Tove Faber Frandsen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial
Mark Robson et al.
EUROPEAN JOURNAL OF CANCER (2019)
Current state of quality of life and patient-reported outcomes research
Andrew Bottomley et al.
EUROPEAN JOURNAL OF CANCER (2019)
Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial
Daniel I. Sessler et al.
LANCET (2019)
Analytical approaches and estimands to take account of missing patient-reported data in longitudinal studies
Melanie L. Bell et al.
PATIENT-RELATED OUTCOME MEASURES (2019)
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols The SPIRIT-PRO Extension
Melanie Calvert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco et al.
ANNALS OF INTERNAL MEDICINE (2018)
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
Zachary Munn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review
Rebecca Mercieca-Bebber et al.
BMJ OPEN (2016)
Handling missing data in RCTs; a review of the top medical journals
Melanie L. Bell et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension
Melanie Calvert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards
Michael Brundage et al.
QUALITY OF LIFE RESEARCH (2013)
The Prevention and Treatment of Missing Data in Clinical Trials: An FDA Perspective on the Importance of Dealing With It
R. T. O'Neill et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
The Prevention and Treatment of Missing Data in Clinical Trials
Roderick J. Little et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Share Paper
